• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biotricity Inc (NQ: BTCY )

    0.4631 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Biotricity Inc

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    SWK Holdings Provides Portfolio Update
    Via ACCESSWIRE
    Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins
    Via ACCESSWIRE
    Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States
    Via ACCESSWIRE
    Biotricity Kicks off Another Pilot Program with a Major Hospital System that Services over 800K Individuals
    Via ACCESSWIRE
    Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025
    Via ACCESSWIRE
    BTCY Stock Earnings: Biotricity Reported Results for Q1 2025
    Biotricity just reported results for the first quarter of 2025. 
    Via InvestorPlace
    Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available
    Via ACCESSWIRE
    Biotricity Provides Year-End Guidance with Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets
    Via ACCESSWIRE
    LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud
    Via ACCESSWIRE
    Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
    Via ACCESSWIRE
    Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    Biotricity Announces Accelerated Path to EBITDA Positive
    Via ACCESSWIRE
    Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program
    Via ACCESSWIRE
    BTCY Stock Earnings: Biotricity Beats EPS, Misses Revenue for Q4 2024
    BTCY stock results show that Biotricity beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024. 
    Via InvestorPlace
    Biotricity Reports Strong Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company's Path to Profitability
    Via ACCESSWIRE
    Biotricity to Host Fourth Quarter and Fiscal Year 2024 Financial Results and Business Update Call on June 27
    Via ACCESSWIRE
    Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market
    Via ACCESSWIRE
    Biotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares into Restricted Common Stock
    Via ACCESSWIRE
    Biotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health Market
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships with Two Leading Home-Based Diagnostic Companies
    Via ACCESSWIRE
    Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers
    Via ACCESSWIRE
    Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics
    Via ACCESSWIRE
    Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital Network
    Via ACCESSWIRE
    Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic... 
    Via Benzinga
    Biotricity Announces a Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities
    Via ACCESSWIRE
    LOBO EV and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    Biotricity Accelerates Market Access by Partnering with Third Major Group Purchasing Organization, Expanding Market Reach to 90% of U.S. Hospitals
    Via ACCESSWIRE
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.